Overview The availability and accessibility of contraception remain a vital issue in women's health. In "Is Contraception Under Attack?" The New Yorker examines the evolving landscape of reproductive health, highlighting recent advancements such as the FDA's approval of the first over-the-counter birth control pill, Opill. This decision is seen as a significant step forward in expanding access to contraception without requiring a doctor's visit. However, the article also explores the growing...